Journal of Inherited Metabolic Disease

, Volume 29, Issue 4, pp 516–525 | Cite as

Classical galactosaemia revisited

metabolic Dissertation


Classical galactosaemia (McKusick 230400) is an: autosomal recessive disorder of galactose metabolism, caused by a deficiency of the enzyme galactose-1-phosphate uridyltransferase (GALT; EC 2.7.712). Most patients present in the neonatal period, after ingestion of galactose, with jaundice, hepatosplenomegaly, hepatocellular insufficiency, food intolerance, hypoglycaemia, renal tubular dysfunction, muscle hypotonia, sepsis and cataract. The gold standard for diagnosis of classical galactosaemia is measurement of GALT activity in erythrocytes. Gas-chromatographic determination of urinary sugars and sugar alcohols demonstrates elevated concentrations of galactose and galactitol. The only therapy for patients with classical galactosaemia is a galactose-restricted diet, and initially all galactose must be removed from the diet as soon as the diagnosis is suspected. After the neonatal period, a lactose-free diet is advised in most countries, without restriction of galactose-containing fruit and vegetables. In spite of the strict diet, long-term complications such as retarded mental development, verbal dyspraxia, motor abnormalities and hypergonadotrophic hypogonadism are frequently seen in patients with classical galactosaemia. It has been suggested that these complications may result from endogenous galactose synthesis or from abnormal galactosylation. Novel therapeutic strategies, aiming at the prevention of galactose 1-phosphate production, should be developed. In the meantime, the follow-up protocol for patients with GALT deficiency should focus on early detection, evaluation and, if possible, early intervention in problems of motor, speech and cognitive development.



endogenous galactose synthesis


follicle-stimulating hormone


galactose 1-phosphate


UDP-galactose epimerase




galactose mutarotase




galactose-1-phosphate uridyltransferase


Health Related Quality of Life


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acosta PB, Gross KC (1995) Hidden sources of galactose in the environment. Eur J Pediatr 154(Suppl 2): s87–92.PubMedCrossRefGoogle Scholar
  2. Ai Y, Zheng Z, O'Brien-Jenkins A, et al (2000) A mouse model of galactose-induced cataracts. Hum Mol Genet 9(12): 1821–1827.PubMedCrossRefGoogle Scholar
  3. Bandyopadhyay S, Chakrabarti J, Banerjee S, et al (2003) Prenatal exposure to high galactose adversely affects initial gonadal pool of germ cells in rats. Hum Reprod 18(2): 276–282.PubMedCrossRefGoogle Scholar
  4. Berry GT, Palmieri M, Gross KC, et al (1993) The effect of fruit and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency. J Inherit Metab Dis 16: 91–100.PubMedCrossRefGoogle Scholar
  5. Berry GT, Nissim I, Lin Z, Mazur AT, Gibson JB, Segal S (1995) Endogenous synthesis of galactose in normal men and patients with hereditary galactosemia. Lancet 346: 1073–1074.PubMedCrossRefGoogle Scholar
  6. Berry GT, Leslie N, Reynolds R, Yager CT, Segal S (2001) Evidence for alternate galactose oxidation in a patient with deletion of the galactose-1-phosphate uridyltransferase gene. Mol Genet Metab 72(4): 316–321.PubMedCrossRefGoogle Scholar
  7. Berry GT, Moate PJ, Reynolds RA et al (2004) The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency. Mol Genet Metab 81: 22–30.PubMedCrossRefGoogle Scholar
  8. Boehles H, Wenzel D, Shin YS (1986) Progressive cerebellar and extrapyramidal motor disturbances in galactosaemic twins. Eur J Pediatrics 145: 413–417.CrossRefGoogle Scholar
  9. Bosch AM, Bakker HD, van Gennip AH, van Kempen JV, Wanders RJ, Wijburg FA (2002) Clinical features of galactokinase deficiency: a review of the literature. J Inherit Metab Dis 25(8): 629–634.PubMedCrossRefGoogle Scholar
  10. Bosch AM, Bakker HD, Maillette de Buy Wenniger-Prick LJ, Wanders RJA, Wijburg FA (2004a) High tolerance for oral galactose in classical galactosemia: dietary implications. Arch Dis Child 89(11): 1034–1036.CrossRefGoogle Scholar
  11. Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HSA, Wijburg FA, Last BF (2004b) Living with classical galactosemia, health related quality of life consequences. Pediatrics 113(5): e423–e428.CrossRefGoogle Scholar
  12. Bosch AM, Ijlst L, Oostheim W, et al (2005) Identification of novel mutations in classical galactosemia. Hum Mutat 25(5): 502.PubMedCrossRefGoogle Scholar
  13. Cuatrecasas P, Segal S (1996) Galactose conversion to d-xylulose. An alternative route of galactose metabolism. Science 153(735): 549–551.Google Scholar
  14. Elsas LJ, Dembure PP, Langley S, Paulk EM, Hjelm LN, Fridovich-Keil J (1994) A common mutation associated with the Duarte galactosemia allele. Am J Hum Genet 54: 1030–1036.PubMedGoogle Scholar
  15. Elsas LJ, Lai K, Saunders CJ, Langley SD (2001) Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 72: 297–305.PubMedCrossRefGoogle Scholar
  16. Fox FP, Lucey JA, Cogan TM (1990) Glycolysis and related reactions during cheese manufacture and ripening. Crit Rev Food Sci Nutr 29(4): 237–253.PubMedCrossRefGoogle Scholar
  17. Gross KC, Acosta PB (1991) Fruit and vegetables are a source of galactose: implications of planning the diets of patients with galactosemia. J Inherit Metab Dis 14: 253–258.PubMedCrossRefGoogle Scholar
  18. Guerrero NV, Dingh RH, Manatunga A, Berry GT, Steiner RD, Elsas LJ (2000) Risk factors for premature ovarian failure in females with galactosemia. J Pediatr 137(6): 833–841.PubMedCrossRefGoogle Scholar
  19. Haberland C, Perou M, Brunngraber EG, Hof H (1971) The neuropathology of galactosemia. A histopathological and biochemical study. J Neuropathol Exp Neurol 30: 431–447.PubMedGoogle Scholar
  20. Hirokawa H, Okano Y, Asada M, Fujimoto A, Suyama I, Isshiki G (1999) Molecular basis for phenotypic heterogeneity in galactosemia: prediction of clinical phenotype from genotype in Japanese patients. Eur J Hum Genet 7(7):757–764.PubMedCrossRefGoogle Scholar
  21. Holden HM, Rayment I, Thoden JB (2003) Structure and function of enzymes of the Leloir pathway for galactose metabolism. J Biol Chem 278(45): 43885–43888.PubMedCrossRefGoogle Scholar
  22. Holton JB (1995) Effects of galactosemia in utero. Eur J Pediatr 154(Supplement 2): s77–81.PubMedCrossRefGoogle Scholar
  23. Holton JB, Walter JH, Tyfield LA (2001) Galactosemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc eds. The Metabolic and Molecular Basis of Inherited Disease, 8th edn. New York: McGraw-Hill, 1553–1583.Google Scholar
  24. Honeyman MM, Green A, Holton JB, Leonard JV (1993) Galactosemia: results of the British Pediatric Surveillance Unit Study, 1988–90. Arch Dis Child 69: 339–341.PubMedGoogle Scholar
  25. Huidekoper HH, Bosch AM, van der Crabben SN, Sauerwein HP, Ackermans MT, Wijburg FA (2005) Short-term exogenous galactose supplementation does not influence rate of appearance of galactose in patients with classical galactosemia. Mol Genet Metab 84(3): 265–272.PubMedCrossRefGoogle Scholar
  26. Hutchesson ACJ, Murdoch-Davies C, Green A, et al (1999) Biochemical monitoring of treatment for galactosemia: biological variability in metabolite concentrations. J Inherit Metab Dis 22: 138–148.Google Scholar
  27. Huttenlocher PR, Hillman RE, Hsia YE (1970) Pseudotumor cerebri in classical galactosemia. J Pediatr 76(6): 902–905.PubMedCrossRefGoogle Scholar
  28. Isselbacher KJ, Anderson EP, Kurahashi K, Kalckar HM (1956) Congenital galactosemia, a single enzymatic block in galactose metabolism. Science 123(3198): 635–636.PubMedGoogle Scholar
  29. Isselbacher KJ (1957) Evidence for an accessory pathway of galactose metabolism in mammalian liver. Science 126: 652–654.PubMedGoogle Scholar
  30. Jaeken J, Kint J, Spaapen LJM (1992) Serum lysosomal enzyme abnormalities in galactosemia. Lancet 340(8833): 1472–1473.PubMedCrossRefGoogle Scholar
  31. Jakobs C, Schweitzer S, Dorland B (1995) Galactitol in galactosemia. Eur J Pediatr 154 (Supplement 2): s50–52.PubMedCrossRefGoogle Scholar
  32. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R (1981) Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 304: 994–998.PubMedCrossRefGoogle Scholar
  33. Kaufman FR, Loro ML, Azen C, Wenz E, Gilzans V (1993) Effect of hypogonadism and deficient calcium intake on bone density in patients with galactosemia. J Pediatr 123(3): 365–370.PubMedCrossRefGoogle Scholar
  34. Kaufman FR, McBride-Chang C, Manis FR, Wolff JA, Nelson MD (1995) Cognitive functioning, neurologic status and brain imaging in classic galactosemia. Eur J Pediatr 154(Supplement 2): s2–5.PubMedCrossRefGoogle Scholar
  35. Kobayashi RH, Kettelhut BV, Kobayashi AL (1983) Galactose inhibition of neonatal neutrophil function. Pediatr Infect Dis 2(6): 442–445.PubMedCrossRefGoogle Scholar
  36. Komrower GM, Lee DH (1970) Long term follow-up of galactosemia. Arch Dis Child 45: 367.PubMedCrossRefGoogle Scholar
  37. Lai K, Langley SD, Singh R, Dembuere PP, Hjelm LN, Elsas LJ (1996) A prevalent mutation for galactosemia among black Americans. J Pediatr 128: 89–95.PubMedCrossRefGoogle Scholar
  38. Lai K, Langley SD, Khwaja FW, Schmitt EW, Elsas LJ (2003) GALT deficiency causes UDP hexose deficit in human galactosemic cells. Glycobiology 13(4): 285–294.PubMedCrossRefGoogle Scholar
  39. Langley SD, Lai K, Dembure PP, Hjelm LN, Elsas LJ (1997) Molecular basis for Duarte and Los Angeles variant galactosemia. Am J Hum Genet 60: 366–372.PubMedGoogle Scholar
  40. Lebea PJ, Pretorius PJ (2005) The molecular relationship between deficient UDP-galactose uridyl transferase (GALT) and ceramide galactosyltransferase (CGT) enzyme function: a possible cause for poor long-term prognosis in classic galactosemia. Med Hypotheses 65(6): 1051–1057.PubMedCrossRefGoogle Scholar
  41. Lee PJ, Lilburn M, Wendel U, Schadewaldt P (2003) A woman with untreated galactosaemia. Lancet 362: 446.PubMedCrossRefGoogle Scholar
  42. Leslie N, Immerman E, Flach J, Florez M, Fridovich-Keil J, Elsas L (1992) The human galactose-1-phosphate uridyltransferase gene. Genomics 14: 474–480.PubMedCrossRefGoogle Scholar
  43. Levy HL, Driscoll SG, Porensky RS, Wender DF (1994) Ovarian failure in galactosemia. N Engl J Med 310: 50.Google Scholar
  44. Lo W, Packmean S, Nash S, et al (1984) Curious neurologic sequelae in galactosemia. Pediatrics 73(3): 309–312.PubMedGoogle Scholar
  45. Menezo YJR, Lescaille M, Nicollet B, Servy EJ (2004) Pregnancy and delivery after stimulation with rFSH of a galactosemia patient suffering hypergonadotropic hypogonadism: case report. J Assist Reprod Genet 3: 89–90.CrossRefGoogle Scholar
  46. Meyer WR, Doyle MB, Grifo JA, et al (1992) Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat. Am J Obstet Gynecol 167: 1837–1843.PubMedGoogle Scholar
  47. Nelson D (1995) Verbal dyspraxia in children with galactosemia. Eur J Pediatr 154 (suppl 2): s6–7.PubMedCrossRefGoogle Scholar
  48. Nelson MD, Wolff JA, Cross CA, Donnell GN, Kaufman FR (1982) Galactosemia: evaluation with MR imaging. Radiology 184: 255–261.Google Scholar
  49. Ning C, Reynolds R, Chen J et al (2000) Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency. Pediatr Res 48(2): 211–217.PubMedGoogle Scholar
  50. Novelli G, Reichardt JKV (2000) Molecular disorders of human galactose metabolism: past, present, and future. Mol Genet Metab 71: 662–665.CrossRefGoogle Scholar
  51. Ornstein KS, McGuire EJ, Berry GT, Roth S, Segal S (1992) Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency. Pediatr Res 31(5): 508–511.PubMedGoogle Scholar
  52. Panis B, Forget P, van Kroonenburgh MJ, et al (2004) Bone metabolism in galactosemia. Bone 35(4): 982–987.PubMedCrossRefGoogle Scholar
  53. Podskarbi T, Kohlmetz T, Gathof B, et al (1996) Molecular characterization of Duarte-1 and Duarte-2 variants of galactose-1-phosphate uridyltransferase. J Inherit Metab Dis 19: 638–644.PubMedCrossRefGoogle Scholar
  54. Prestoz LLC, Couto AS, Shin YS, Petry KG (1997) Altered follicle stimulated hormone isoforms in female galactosemia patients. Eur J Pediatr 156: 116–120.PubMedCrossRefGoogle Scholar
  55. Ridel KR, Leslie ND, Gilbert DL (2005) An updated 7 of the long term neurological effects of galactosemia. Pediatr Neurol 33(3): 153–161.PubMedCrossRefGoogle Scholar
  56. Robertson AMPH, Singh RH, Guerrero NV, Hundley M, Elsas LJ (2000) Outcome analysis of verbal dyspraxia in classic galactosemia. Genet Med 2(2): 142–148.PubMedCrossRefGoogle Scholar
  57. Rubio-Gozalbo ME, Hamming S, van Kroonenburg MJ, et al (2002) Bone mineral density in patients with classic galactosemia. Arch Dis Child 87(1): 57–60.PubMedCrossRefGoogle Scholar
  58. Schadewaldt P, Amalanathan L, Hammen HW, Wendel U (2004a) Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients. Mol Genet Metab 81: 31–44.CrossRefGoogle Scholar
  59. Schadewaldt P, Lilburn M, Wendel U, Lee P (2004b) Unexpected outcome in untreated galactosaemia. [Letter to the editor]. Mol Genet Metab 81: 255–257.CrossRefGoogle Scholar
  60. Schweitzer S, Shin Y, Jacobs C, Brodehl J (1993) Long-term outcome in 134 patients with galactosaemia. Eur J Paediatr 152: 36–43.CrossRefGoogle Scholar
  61. Schweitzer-Krantz S (2003) Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia. Eur J Pediatr 162(Supplement 1): S50–53.PubMedCrossRefGoogle Scholar
  62. Segal S (1998) Komrower Lecture. Galactosemia today: the enigma and the challenge. J Inherit Metab Dis 21(5): 455–471.PubMedCrossRefGoogle Scholar
  63. Segal S (2004) Another aspect of the galactosemic enigma. [Letter to the editor]. Mol Genet Metab 81: 253–254.PubMedCrossRefGoogle Scholar
  64. Shield JPH, Wadswordt EJK, MacDonald A, et al (2000) The relationship of genotype to cognitive outcome in galactosemia. Arch Dis Child 83: 248–250.PubMedCrossRefGoogle Scholar
  65. Shin-Buehring YS, Schaub J (1980) Pitfalls in the radioactive method of galactose-1-phosphate uridyltransferase activity measurement. Clin Chim Acta 106: 231–234.PubMedCrossRefGoogle Scholar
  66. Shin YS, Niedermeier HP, Endres W, Schaub J, Weidinger S (1987) Agarose gel isofocusing of UDP galactose pyrophosphorylase and galactose-1-phosphate uridyltrasferase. Developmental aspect of UDP-galactose pyrophosphorylase. Clin Chim Acta 166: 27–35.PubMedCrossRefGoogle Scholar
  67. Stambolian D (1988) Galactose and cataract. Surv Ophthalmol 32(5): 333–349.PubMedCrossRefGoogle Scholar
  68. Thompson SM, Netting MJ, Jerath S, Wiley V (2003) Effect of a less restricted diet in galactosemia. J Inherit Metab Dis 26(Supplement 2): 214.Google Scholar
  69. Tyfield L, Carmichael D. The galactose-1-phosphate uridyltransferase mutation analysis database home page. (GALTdB) at
  70. Tyfield L, Reichardt J, Fridovich-Keil J, et al (1999) Classical galactosemia and mutations at the galactose-1-phosphate uridyltransferase (GALT) gene. Hum Mutat 13: 417–430.PubMedCrossRefGoogle Scholar
  71. Vannas A, Hogan MJ, Golbus MS, Wood I (1975) Lens changes in a galactosemic fetus. Am J Ophthalmol 80(4): 726–733.PubMedGoogle Scholar
  72. Waggoner DD, Buist NRM, Donnell GN (1990) Long-term prognosis in galactosemia: results of a survey of 350 cases. J Inherit Metab Dis 13: 802–818.PubMedCrossRefGoogle Scholar
  73. Webb AL, Singh RH, Kennedy MJ, Elsas LJ (2003) Verbal dyspraxia and galactosemia. Pediatr Res 53(3): 396–402.PubMedCrossRefGoogle Scholar
  74. Wehrli SL, Berry GT, Palmieri M, Mazur A, Elsas L, Segal S (1997) Urinary galactonate in patients with galactosemia: quantitation by nuclear magnetic resonance spectroscopy. Pediatr Res 42(6): 855–861.PubMedGoogle Scholar
  75. Xu YK, Ng WG, Kaufman FR, Lobo RA, Donnell GN (1989) Galactose metabolism in human ovarian tissue. Pediatr Res 25(2): 151–155.PubMedGoogle Scholar

Copyright information

© SSIEM and Springer 2006

Authors and Affiliations

  1. 1.Department of Pediatrics, Division of Metabolic Disorders, Academic Medical Centre (G8 205)University Hospital of AmsterdamAmsterdamThe Netherlands

Personalised recommendations